{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:48:14Z","timestamp":1789181294045,"version":"build-2803163510"},"reference-count":87,"publisher":"Georg Thieme Verlag KG","issue":"03","funder":[{"name":"KU Leuven, Belgium","award":["C1 project C14\/18\/087"],"award-info":[{"award-number":["C1 project C14\/18\/087"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>Promising preclinical data suggested that bone marrow\u2013derived mesenchymal stem cells (BM-MSC) can reduce hepatic fibrosis and stimulate liver regeneration. Preclinical studies moreover suggested that the immunomodulatory and anti-inflammatory functions of MSCs may reduce hepatic inflammation, improve liver function, and decrease infection incidences which are deemed especially important in the case of acute-on-chronic liver failure (ACLF). Studies in patients with decompensated cirrhosis demonstrated that injection of BM-MSC resulted in an improvement of biochemical tests and led to a survival benefit in ACLF. Most of these studies were performed in hepatitis B virus infected patients. However, two adequately powered studies performed in Europe could not confirm these data. A possible alternative to mobilize BM-MSC into the liver is the use of granulocyte colony-stimulating factor (G-CSF) which has proregenerative and immunomodulatory effects. In Indian studies, the use of G-CSF was associated with improvement of survival, although this finding could not be confirmed in European studies. Human allogeneic liver-derived progenitor cell therapy represents a potential treatment for ACLF, of which the main action is paracrine. These human liver\u2013derived MSC can perform various functions, including the downregulation of proinflammatory responses. The clinical beneficial effect of these cells is further explored in patients with alcoholic cirrhosis and ACLF in Europe.<\/jats:p>","DOI":"10.1055\/s-0042-1755328","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:12:33Z","timestamp":1662077553000},"page":"283-292","source":"Crossref","is-referenced-by-count":12,"title":["Mesenchymal Stem Cell Transplantation in Liver Diseases"],"prefix":"10.1055","volume":"42","author":[{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Laboratory of Hepatology, Metabolism and Aging (CHROMETA), University of Leuven, Leuven, Belgium"},{"name":"Division of Hepatology, Department of Gastroenterology and Hepatology, University Hospital KU Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schalk","family":"van der Merwe","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Laboratory of Hepatology, Metabolism and Aging (CHROMETA), University of Leuven, Leuven, Belgium"},{"name":"Division of Hepatology, Department of Gastroenterology and Hepatology, University Hospital KU Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"V Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/hep.28812","article-title":"Time trends in the health care burden and mortality of acute on chronic liver failure in the United States","volume":"64","author":"A M Allen","year":"2016","journal-title":"Hepatology"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jhep.2018.04.025","article-title":"The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations","volume":"69","author":"P Meersseman","year":"2018","journal-title":"J Hepatol"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"P Mathurin","year":"2002","journal-title":"J Hepatol"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","article-title":"Acute-on chronic liver failure","volume":"57","author":"R Jalan","year":"2012","journal-title":"J Hepatol"},{"issue":"03","key":"ref6","first-page":"237","article-title":"Optimization of perfluorocarbon emulsion properties for enhancing mass transfer in a bio-artificial liver support system","volume":"19","author":"F S Moolman","year":"2004","journal-title":"Biochem J"},{"issue":"20","key":"ref7","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1016\/j.biomaterials.2006.02.013","article-title":"Standardization criteria for an ischemic surgical model of acute hepatic failure in pigs","volume":"27","author":"M Nieuwoudt","year":"2006","journal-title":"Biomaterials"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(05)75157-6","article-title":"Europe supports moratorium on xenotransplantation","volume":"353","author":"D Bousingen","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1517\/14712598.2014.950651","article-title":"Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications","volume":"14","author":"M van Wenum","year":"2014","journal-title":"Expert Opin Biol Ther"},{"issue":"08","key":"ref10","doi-asserted-by":"crossref","first-page":"e12101","DOI":"10.1371\/journal.pone.0012101","article-title":"Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells","volume":"5","author":"P Roelandt","year":"2010","journal-title":"PLoS One"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2012.03.030","article-title":"Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus","volume":"57","author":"P Roelandt","year":"2012","journal-title":"J Hepatol"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.sla.0000124298.74199.e5","article-title":"Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure","volume":"239","author":"A A Demetriou","year":"2004","journal-title":"Ann Surg"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"J Thompson","year":"2018","journal-title":"Liver Transpl"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep.1840170216","article-title":"Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells","volume":"17","author":"J Rozga","year":"1993","journal-title":"Hepatology"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1525-1594.2005.00156.x","article-title":"Hepatocyte function in a radial-flow bioreactor using a perfluorocarbon oxygen carrier","volume":"29","author":"M J Nieuwoudt","year":"2005","journal-title":"Artif Organs"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpg.2012.01.002","article-title":"Artificial liver support devices as treatment option for liver failure","volume":"26","author":"F Nevens","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"R Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"A Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1756284819879565","DOI":"10.1177\/1756284819879565","article-title":"Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity","volume":"12","author":"R Ba\u00f1ares","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCC.0000000000000584","article-title":"Artificial liver support in acute and acute-on-chronic liver failure","volume":"25","author":"F S Larsen","year":"2019","journal-title":"Curr Opin Crit Care"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"F S Larsen","year":"2016","journal-title":"J Hepatol"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","article-title":"Innate immune cells in cirrhosis","volume":"73","author":"C Bernsmeier","year":"2020","journal-title":"J Hepatol"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"A Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Y Jiang","year":"2002","journal-title":"Nature"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal stem cells current clinical applications: a systematic review","volume":"52","author":"D E Rodr\u00edguez-Fuentes","year":"2021","journal-title":"Arch Med Res"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"M Di Nicola","year":"2002","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"K Le Blanc","year":"2004","journal-title":"Lancet"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/TP.0b013e31819b3d72","article-title":"Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients","volume":"87","author":"M J Crop","year":"2009","journal-title":"Transplantation"},{"issue":"05","key":"ref29","doi-asserted-by":"crossref","first-page":"e19569","DOI":"10.1371\/journal.pone.0019569","article-title":"Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells","volume":"6","author":"J Ferrand","year":"2011","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"130763","DOI":"10.1155\/2013\/130763","article-title":"Mesenchymal stem cells migration homing and tracking","volume":"2013","author":"A Sohni","year":"2013","journal-title":"Stem Cells Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"K Le Blanc","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/81326","article-title":"Purified hematopoietic stem cells can differentiate into hepatocytes in vivo","volume":"6","author":"E Lagasse","year":"2000","journal-title":"Nat Med"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.20452","article-title":"Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice","volume":"40","author":"I Sakaida","year":"2004","journal-title":"Hepatology"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep.20214","article-title":"Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells","volume":"39","author":"N Fausto","year":"2004","journal-title":"Hepatology"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10238-010-0105-6","article-title":"Effect of allogeneic bone marrow-derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model","volume":"11","author":"D Wang","year":"2011","journal-title":"Clin Exp Med"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.gastro.2017.03.022","article-title":"Sphingosine-1-phosphate prevents egress of hematopoietic stem cells from liver to reduce fibrosis","volume":"153","author":"A King","year":"2017","journal-title":"Gastroenterology"},{"issue":"08","key":"ref37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2016.97","article-title":"Liver regeneration - mechanisms and models to clinical application","volume":"13","author":"S J Forbes","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/jhep.2000.9124","article-title":"Liver from bone marrow in humans","volume":"32","author":"N D Theise","year":"2000","journal-title":"Hepatology"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMoa3461002","article-title":"Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells","volume":"346","author":"M K\u00f6rbling","year":"2002","journal-title":"N Engl J Med"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.gastro.2008.05.040","article-title":"Critical review of clinical trials of bone marrow stem cells in liver disease","volume":"135","author":"D D Houlihan","year":"2008","journal-title":"Gastroenterology"},{"issue":"07","key":"ref41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/apt.12645","article-title":"Systematic review: the effects of autologous stem cell therapy for patients with liver disease","volume":"39","author":"J K Moore","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-018-0816-2","article-title":"A pooled analysis of mesenchymal stem cell-based therapy for liver disease","volume":"9","author":"L Zhao","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","article-title":"Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study","volume":"22","author":"A C Lyra","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/liv.12228","article-title":"Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis","volume":"33","author":"M Mohamadnejad","year":"2013","journal-title":"Liver Int"},{"issue":"26","key":"ref45","doi-asserted-by":"crossref","first-page":"8660","DOI":"10.3748\/wjg.v20.i26.8660","article-title":"Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis","volume":"20","author":"Y Q Bai","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"06","key":"ref46","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial","volume":"64","author":"K T Suk","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.dld.2015.08.018","article-title":"Reinfusion of highly purified CD133+ bone marrow-derived stem\/progenitor cells in patients with end-stage liver disease: A phase I clinical trial","volume":"47","author":"P Andreone","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4252\/wjsc.v12.i10.1124","article-title":"Still 'dwelling in the possibility' - critical update on stem cell therapy for acute on chronic liver failure","volume":"12","author":"C A Philips","year":"2020","journal-title":"World J Stem Cells"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5966\/sctm.2012-0034","article-title":"Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients","volume":"1","author":"M Shi","year":"2012","journal-title":"Stem Cells Transl Med"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.29189","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial","volume":"66","author":"B L Lin","year":"2017","journal-title":"Hepatology"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","article-title":"Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes","volume":"54","author":"L Peng","year":"2011","journal-title":"Hepatology"},{"issue":"02","key":"ref52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2141.2003.04745.x","article-title":"Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization","volume":"124","author":"K Fujii","year":"2004","journal-title":"Br J Haematol"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.gastro.2007.05.018","article-title":"Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats","volume":"133","author":"A C Piscaglia","year":"2007","journal-title":"Gastroenterology"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"L Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"V Garg","year":"2012","journal-title":"Gastroenterology"},{"issue":"07","key":"ref56","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3748\/wjg.v19.i7.1104","article-title":"Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure","volume":"19","author":"X Z Duan","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"09","key":"ref57","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"V Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"C K Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MEG.0000000000000801","article-title":"Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial","volume":"29","author":"R Prajapati","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.29763","article-title":"Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial","volume":"68","author":"N Verma","year":"2018","journal-title":"Hepatology"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cgh.2020.02.022","article-title":"Multiple cycles of granulocyte colony-stimulating factor increase survival times of patients with decompensated cirrhosis in a randomized trial","volume":"19","author":"A De","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"02","key":"ref62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jceh.2019.05.003","article-title":"Granulocyte colony-stimulating factor use in decompensated cirrhosis: lack of survival benefit","volume":"10","author":"C A Philips","year":"2020","journal-title":"J Clin Exp Hepatol"},{"issue":"05","key":"ref63","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1053\/gast.1997.v113.pm9352864","article-title":"Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety","volume":"113","author":"A Donaghy","year":"1997","journal-title":"Gastroenterology"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/liv.13923","article-title":"Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis","volume":"39","author":"L Anand","year":"2019","journal-title":"Liver Int"},{"issue":"06","key":"ref65","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jhep.2021.07.033","article-title":"Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study)","volume":"75","author":"C Engelmann","year":"2021","journal-title":"J Hepatol"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.jhepr.2020.100139","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"A Marot","year":"2020","journal-title":"JHEP Rep"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0041-1723034","article-title":"The current status of granulocyte-colony stimulating factor to treat acute-on-chronic liver failure","volume":"41","author":"C Engelmann","year":"2021","journal-title":"Semin Liver Dis"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"e53719","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"L Spahr","year":"2013","journal-title":"PLoS One"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"P N Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.24315","article-title":"Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function","volume":"53","author":"J A Thomas","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"ref71","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1136\/gutjnl-2018-316888","article-title":"Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity","volume":"68","author":"H Korf","year":"2019","journal-title":"Gut"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jhep.2020.11.029","article-title":"The multifactorial mechanisms of bacterial infection in decompensated cirrhosis","volume":"75","author":"S Van der Merwe","year":"2021","journal-title":"J Hepatol"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","article-title":"Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function","volume":"58","author":"J Du Plessis","year":"2013","journal-title":"J Hepatol"},{"issue":"07","key":"ref74","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3727\/000000007783465154","article-title":"Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes?","volume":"16","author":"M Najimi","year":"2007","journal-title":"Cell Transplant"},{"issue":"08","key":"ref75","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/TP.0000000000001773","article-title":"Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia a patient","volume":"101","author":"E M Sokal","year":"2017","journal-title":"Transplantation"},{"issue":"05","key":"ref76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.21037\/hbsn.2018.05.01","article-title":"Cytokinome of adult-derived human liver stem\/progenitor cells: immunological and inflammatory features","volume":"7","author":"M Najar","year":"2018","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"8250584","DOI":"10.1155\/2019\/8250584","article-title":"Human hepatocytes and differentiated adult-derived human liver stem\/progenitor cells display in vitro immunosuppressive properties mediated, at least in part, through the nonclassical HLA Class I molecule HLA-G","volume":"2019","author":"C A Lombard","year":"2019","journal-title":"J Immunol Res"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2679518","DOI":"10.1155\/2017\/2679518","article-title":"Immunoprofiling of adult-derived human liver stem\/progenitor cells: impact of hepatogenic differentiation and inflammation","volume":"2017","author":"H El-Kehdy","year":"2017","journal-title":"Stem Cells Int"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13287-017-0575-5","article-title":"Human liver mesenchymal stem\/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation","volume":"8","author":"M Najimi","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"04","key":"ref80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2004-815564","article-title":"Progenitor cells in diseased human liver","volume":"23","author":"T A Roskams","year":"2003","journal-title":"Semin Liver Dis"},{"issue":"10","key":"ref81","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1478-3231.2006.01377.x","article-title":"Liver regeneration in acute severe liver impairment: a clinicopathological correlation study","volume":"26","author":"A Katoonizadeh","year":"2006","journal-title":"Liver Int"},{"issue":"06","key":"ref82","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis","volume":"55","author":"P Sancho-Bru","year":"2012","journal-title":"Hepatology"},{"issue":"06","key":"ref83","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: time to change the name!","volume":"6","author":"A I Caplan","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"09","key":"ref84","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/TP.0000000000002605","article-title":"Phase I\/II trial of liver-derived mesenchymal stem cells in pediatric liver-based metabolic disorders: a prospective, open label, multicenter, partially randomized, safety study of one cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in urea cycle disorders and Crigler-Najjar syndrome patients","volume":"103","author":"F Smets","year":"2019","journal-title":"Transplantation"},{"issue":"10","key":"ref85","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.3727\/096368912X639026","article-title":"Adult-derived human liver progenitor cells in long-term culture maintain appropriate gatekeeper mechanisms against transformation","volume":"21","author":"I Scheers","year":"2012","journal-title":"Cell Transplant"},{"issue":"11","key":"ref86","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gut.2009.189639","article-title":"Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study","volume":"59","author":"A Katoonizadeh","year":"2010","journal-title":"Gut"},{"issue":"04","key":"ref87","doi-asserted-by":"crossref","first-page":"100291","DOI":"10.1016\/j.jhepr.2021.100291","article-title":"A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation","volume":"3","author":"F Nevens","year":"2021","journal-title":"JHEP Rep"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1755328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:13:36Z","timestamp":1662077616000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1755328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":87,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,8,24]]},"published-print":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1755328","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}